SCI Pharmtech Revenue

In the year 2024, SCI Pharmtech had annual revenue of 1.52B TWD with 26.54% growth. SCI Pharmtech had revenue of 401.85M in the quarter ending December 31, 2024, with 37.90% growth.

Revenue

1.52B

Revenue Growth

+26.54%

P/S Ratio

6.14

Revenue / Employee

6.38M

Employees

239

Market Cap

9.36B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.52B	319.58M	26.54%
Dec 31, 2023	1.20B	304.42M	33.83%
Dec 31, 2022	899.74M	35.52M	4.11%
Dec 31, 2021	864.22M	-1.83B	-67.86%
Dec 31, 2020	2.69B	333.48M	14.16%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	9.73B
Caliway Biopharmaceuticals	44.43M
Bora Pharmaceuticals Co., LTD.	19.25B
Lotus Pharmaceutical	18.58B
Oneness Biotech	117.93M
Lumosa Therapeutics	39.15M
Pegavision	6.82B
Polaris Group	107.00M

Revenue Rankings